References
- Biffignandi P., Massuchettic C., Molinatti G. M. Female hirsutism: pathophysiological considerations and therapeutic implications. Endocr. Rev. 1984; 5: 498–513
- Ferriman D., Gallwey J. D. Clinical assessment of body hair growth in women. J. Clin. Endocrinol. Metab. 1961; 21: 1440–7
- Sufrin G., Coffey D. S. Flutamide: mechanisms of action of a new non steroidal antiandrogen. Invest. Urol. 1976; 13: 429–35
- Neri R., Florance K., Koziol P., Van Cleave S. A biological profile of a nonsteroidal antiandrogen, SHG 13521 (4′-nitro-3′-trifluoro methylisobutyranilide. Endocrinology 1972; 91: 427–37
- Sogani P. C., Vagaiwala M. R., Whitmore W. F. Experience with flutamide in patients with advanced prostatic cancer without prior endocrine therapy. Cancer 1984; 54: 744–50
- Gomez J.-L., Dupont A., Cusan L., Tremblay M., Suburu R., Leniay M., Labrie F. Incidence of liver toxicity associated with the use of flutamide in prostate cancer patients. Am. J. Med. 1992; 92: 465–70
- Belisle S., Love E. J. Clinical efficacy and safety of cyproterone acetate in severe hirsutism: results of a multicentered Canadian study. Fertil. Steril. 1986; 46: 1015–20
- Kaiser E., Gruner S. Long term studies with an antiandrogen/estrogen combination preparation of its effectiveness, liver tolerance and lipid metabolism in females. Ceburtshilfe-Frauenheilk. 1991; 51: 298–303
- Plante M., Lapointe S., Labrie F. Stimulatory effect of synthetic progestins currently used for the treatment of prostate cancer on growth of the androgen-sensitive Shionogi tumor in mice. J. Steroid Biochem. 1988; 31: 845–52
- Marcondes J. A. M., Wajchenberg B. L., Abujamra A. C., Luthoid W. W., Samojilik E., Kirschner M. A. Monthly cyproterone acetate in the treatment of hirsute women: clinical and laboratory effects. Fertil. Steril. 1990; 53: 40–4
- Hellman L., Bradlow H. L., Freed S., Levin J., Rosenfeld R. S., Whitmore W. F., Kiddy D. S. The effect of flutamide on testosterone metabolism and the plasma levels of androgens and gonadotropins. J. Clin. Endocrinol. Metab. 1977; 45: 1224–9
- Cusan L., Dupont A., Balanger A., Tremblay R. R., Mahhes G., Labrie F. Treatment of hirsutism with the pure antiandrogen flutamide. J. Am. Acad. Dermatol. 1990; 23: 462–9
- Marcondes J. A. M., Minnari S. L., Luthold W. W., Wajchenberg B. L., Samojilik E., Kirschner M. A. Treatment of hirsutism in women with flutamide. Fertil. Steril. 1992; 57: 543–7
- Motta T., Maggi G., Perra M., Azzolari E., Casazza S., D'Alberton A. Flutamide in the treatment of hirsutisni. Int. J. Gyriecol. Obstet. 1991; 36: 155–7
- Sciarra F., Toscano V., Concolino G., Di Silveti F. Antiandrogens: clinical applications. J. Steroid Biochem. Mol. Biol. 1990; 37: 349–54
- Fruzzetti F., De Lorenzo D., Ricci C., Fioretti P. Clinical and endocrine effects of flutamide in hyperandrogenic women. Fertil. Steril. 1993; 60: 806–13
- Erenks M., Gurbuz O., Durmusoglu F., Demircay Z., Pekin S. Comparison of the efficacy of spironolactone versus flutamide in the treatment of hirsutisni. Fertil. Steril. 1904; 61: 613–16
- Moller S., Iversen P., Franzmann M.-B. Flutamide induced liver failure. J. Hepatol. 1990; 10: 346–9
- Wallace C., Lalor E. A., Chick C. L. Hepatotoxicity complicating flutamide treatment of hirsutism. Awn. Interm. Med. 1993; 119: 1150–4
- Cusan L., Dupont A., Gomez J. L., Tremblay R. R., Labrie F. Comparison of flutamide and spironolactone in the treatment of hirsutism: a randomized controlled trial. Fertil. Steril. 1994; 61: 281–7